The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-Greece bans export of 25 drugs after pharmacists' supply warnings

Tue, 14th Jul 2015 17:14

(Adds AstraZeneca comment)

By Lefteris Karagiannopoulos

ATHENS, July 14 (Reuters) - Greece has decided to ban theexport of 25 types of drugs, the Health Ministry said onTuesday, following warnings of possible shortages that riskedleading to a humanitarian crisis.

A ministry spokeswoman quoted the Greek drugs regulator assaying there had been a significant increase in some importedmedicines being shipped back out of the country.

"Abuses by some players in the pharmaceuticals market havebeen discovered," she told Reuters.

The regulator made the warning on re-exports during ameeting at the Health Ministry on Friday, when pharmacistscomplained they faced difficulties in securing some supplies.

The spokeswoman said the ministry would closely checkexports and re-exports over the past 15 days and file complaintsat home and abroad where there is evidence of abuse. Shedeclined to say which drugs would be included in the ban.

However, the head of the drugs wholesalers' association saidthe group had not yet been informed of the ban.

The ban was the latest move in a row over the availabilityof drugs in Greece, with pharmacists, drugmakers, wholesalersand public authorities trading blame while rights group warn ofworsening public health conditions during the economic crisis.

Difficulties over drug supplies in Greece are compounded bycapital controls which prevent companies from sending moneyabroad, imposed last month to prevent the banking system fromcollapse.

Re-exporting drugs across European borders, which allowstraders to buy products in low-cost markets and sell them whereprices are higher, is permitted under European Union free traderules.

Drugmakers have nevertheless urged a curb on re-exports toprevent shortages in Greece but wholesalers trading medicineshave denied the need for such emergency action.

The European Federation of Pharmaceutical Industries andAssociations (EFPIA), which represents 40 drug companies, calledon Tuesday for "exceptional measures" in "exceptionalcircumstances".

"A proportionate, legislative ban on exporting medicinesintended for Greek patients from Greece would be an appropriateand justifiable response to possible shortages and help to averta potential humanitarian crisis," it said in a statement.

But the head of the Hellenic Association of MedicineWholesalers, Eirini Markaki, pointed the finger at internationaldrugmakers and pharmacists. "Most of the internationalpharmaceutical companies have issued quotas on the amount ofsupplies Greek warehouses can order," Markaki told Reuters.

"We have filed official complaints to the regulator so thatmeasures are taken for this to stop," she said, adding that thecomplaints targeted AstraZeneca, Novartis andJanssen, a unit of Johnson & Johnson. Novartis deniedthat it had limited its supplies to Greece, while Janssen wasnot immediately available for comment.

ASTRAZENECA DENIAL

A spokesperson for AstraZeneca said the firm had met theregulator last week "to dispute the allegations made by theHellenic Association of Pharmaceutical Warehouses".

At that meeting, AstraZeneca said, it had "provided evidenceto demonstrate that we continue to deliver in excess of thequantities of medicines currently required in the Greek market".

Markaki denied any overall increase in re-exports bywholesalers. She said an isolated case of one warehouseexporting 700,000 units of drugs in two days at the end of Junewas under investigation, but all the warehouses combined hadexported only 179,000 items so far in July.

Demand for drugs had increased because customers were tryingto build up their supplies, fearing future shortages, she added.

The pharmaceuticals industry is owed more than 1.1 billioneuros by Greek hospitals and the state-run health insurer inunpaid bills since December but it has promised to keep supplylines open on humanitarian grounds.

Separately, Greek pharmacists will go on strike on Wednesdayto protest about plans in a deal struck between Athens and itsinternational lenders on Monday to make changes to their trade.These include allowing people without a pharmacist's degree toopen a pharmacy. (Additional reporting by Kate Kelland in London; Writing byIngrid Melander; Editing by David Stamp)

More News
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.